Journal article
Reprogramming cancer cells: overview & current progress
Kian Lam Lim, Hoon Koon Teoh, Pei Feng Choong, Hui Xin Teh, Soon Keng Cheong, Tunku Kamarul
EXPERT OPINION ON BIOLOGICAL THERAPY | TAYLOR & FRANCIS LTD | Published : 2016
Abstract
INTRODUCTION: Cancer is a disease with genetic and epigenetic origins, and the possible effects of reprogramming cancer cells using the defined sets of transcription factors remain largely uninvestigated. In the handful of publications available so far, findings have shown that reprogramming cancer cells changed the characteristics of the cells to differ from the parental cancer cells. These findings indicated the possibility of utilizing reprogramming technology to create a disease model in the laboratory to be used in studying the molecular pathogenesis or for drug screening of a particular cancer model. AREAS COVERED: Despite numerous methods employed in generating induced pluripotent ste..
View full abstractGrants
Awarded by HIR-MoE Grant
Funding Acknowledgements
This work is supported by HIR-MoE Grant (Reference number - UM.C/625/1/HIR/MOHE/CHAN/03, account number - A000003-50001). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.